Point72 Hong Kong LTD Athersys, Inc Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $9,271 - $44,296	51,508 Added 405.83%	64,200 $17,000
Q1 2022 May 16, 2022	BUY	$0.6 - $1.06 $3,769 - $6,658	6,282 Added 98.0%	12,692 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $5,448 - $8,974	6,410 New	6,410 $6,000
Q3 2018 Nov 14, 2018	SELL	$1.86 - $2.18 $3,240 - $3,797	-1,742 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.76 - $2.79 $3,065 - $4,860	1,742 New	1,742 $3,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.